The 36-month beta value for AVXL is at 0.79. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AVXL is 82.52M, and currently, shorts hold a 30.55% of that float. The average trading volume for AVXL on July 03, 2025 was 935.80K shares.
AVXL) stock’s latest price update
The stock of Anavex Life Sciences Corporation (NASDAQ: AVXL) has increased by 13.29% when compared to last closing price of $9.33.Despite this, the company has seen a gain of 12.33% in its stock price over the last five trading days. globenewswire.com reported 2025-06-16 that PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) — The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex”) on behalf of the company’s long-term shareholders.
AVXL’s Market Performance
AVXL’s stock has risen by 12.33% in the past week, with a monthly rise of 39.81% and a quarterly rise of 31.80%. The volatility ratio for the week is 7.15% while the volatility levels for the last 30 days are 5.41% for Anavex Life Sciences Corporation The simple moving average for the last 20 days is 19.87% for AVXL’s stock, with a simple moving average of 26.22% for the last 200 days.
Analysts’ Opinion of AVXL
Many brokerage firms have already submitted their reports for AVXL stocks, with Cantor Fitzgerald repeating the rating for AVXL by listing it as a “Neutral.” The predicted price for AVXL in the upcoming period, according to Cantor Fitzgerald is $11 based on the research report published on December 06, 2022 of the previous year 2022.
Berenberg, on the other hand, stated in their research note that they expect to see AVXL reach a price target of $40. The rating they have provided for AVXL stocks is “Buy” according to the report published on June 23rd, 2022.
BTIG Research gave a rating of “Buy” to AVXL, setting the target price at $35 in the report published on September 23rd of the previous year.
AVXL Trading at 23.04% from the 50-Day Moving Average
After a stumble in the market that brought AVXL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.80% of loss for the given period.
Stock Fundamentals for AVXL
The total capital return value is set at -0.39. Equity return is now at value -40.13, with -36.00 for asset returns.
Currently, EBITDA for the company is -45.29 million with net debt to EBITDA at 4.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.74.
Conclusion
In conclusion, Anavex Life Sciences Corporation (AVXL) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
